Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sinotau Pharmaceutical Group

Clinical trials sponsored by Sinotau Pharmaceutical Group, explained in plain language.

Trials to join now! 4 Not yet finished but already full! 1 Terminated 1

Radioactive injection shows promise in slowing neuroendocrine tumor growth

Disease control Ongoing

This Phase 3 study tested a radioactive drug called Lutetium-177 oxodotreotide against a high dose of the standard drug octreotide in 196 people with advanced neuroendocrine tumors that had stopped responding to treatment. The main goal was to see if the radioactive drug could de…

Phase: PHASE3 • Sponsor: Sinotau Pharmaceutical Group • Aim: Disease control

Last updated Jun 26, 2026 14:18 UTC